Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
54
ARDX Quote, Financials, Valuation and Earnings
Last price:
$6.15
Seasonality move
:
0.32%
Day range:
$5.77 - $5.91
52-week range:
$3.21 - $6.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.53x
P/B ratio:
9.18x
Volume:
3.4M
Avg. volume:
2.8M
1-year change:
14.99%
Market cap:
$1.4B
Revenue:
$333.6M
EPS (TTM):
-$0.24
Analysts' Opinion
-
Consensus RatingArdelyx, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $11.70, Ardelyx, Inc. has an estimated upside of 100.69% from its current price of $5.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing 100% downside risk from its current price of $5.83.
Fair Value
-
According to the consensus of 11 analysts, Ardelyx, Inc. has 100.69% upside to fair value with a price target of $11.70 per share.
ARDX vs. S&P 500
-
Over the past 5 trading days, Ardelyx, Inc. has overperformed the S&P 500 by 1.76% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Ardelyx, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ardelyx, Inc. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Ardelyx, Inc. reported revenues of $110.3M.
Earnings Growth
-
Ardelyx, Inc. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Ardelyx, Inc. reported earnings per share of -$0.00.
Enterprise value:
1.4B
EV / Invested capital:
--
Price / LTM sales:
3.53x
EV / EBIT:
--
EV / Revenue:
3.47x
PEG ratio (5yr expected):
-0.11x
EV / Free cash flow:
-24.96x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$348.6M
Return On Assets:
-13.05%
Net Income Margin (TTM):
-14.2%
Return On Equity:
-36.67%
Return On Invested Capital:
-17.69%
Operating Margin:
4.23%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $134.3M | $251.8M | $398.2M | $98.2M | $110.3M | |
| Gross Profit | $114.7M | $212.6M | $348.6M | $82M | $105.4M | |
| Operating Income | -$23.1M | -$64.1M | -$38M | $2.2M | $4.7M | |
| EBITDA | -$18.5M | -$62.2M | -$35.3M | $2.8M | $5.6M | |
| Diluted EPS | -$0.12 | -$0.31 | -$0.24 | -$0.00 | -$0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $153.4M | $119.9M | $241.2M | $284.1M | $368M | |
| Total Assets | $170.8M | $144.7M | $289.4M | $367.9M | $486.2M | |
| Current Liabilities | $68.8M | $52M | $43.5M | $70.5M | $83.4M | |
| Total Liabilities | $89.4M | $77.8M | $98.2M | $209.6M | $331.9M | |
| Total Equity | $81.4M | $66.9M | $191.2M | $158.3M | $154.3M | |
| Total Debt | $65.5M | $33.4M | $30.1M | $101.9M | $206.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$66.7M | -$63.3M | -$53.6M | $501K | $365K | |
| Cash From Investing | -$100.2M | -$6.3M | -$54.4M | $2.3M | -$50.5M | |
| Cash From Financing | $139.1M | $83.3M | $103.3M | $2.7M | $2.8M | |
| Free Cash Flow | -$67.1M | -$63.8M | -$55.3M | $364K | $209K | |
ARDX
Sector
Market Cap
$1.4B
$28.1M
Price % of 52-Week High
85.99%
50%
Dividend Yield
0%
0%
Shareholder Yield
-1.98%
-1.54%
1-Year Price Total Return
14.99%
-17.67%
Beta (5-Year)
0.558
0.503
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$5.79
200-day SMA
Buy
Level
$5.06
Bollinger Bands (100)
Buy
Level
5.32 - 6.24
Chaikin Money Flow
Sell
Level
-419.4M
20-day SMA
Sell
Level
$5.86
Relative Strength Index (RSI14)
Buy
Level
50.81
ADX Line
Buy
Level
17.71
Williams %R
Neutral
Level
-74.359
50-day SMA
Buy
Level
$5.68
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
548.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.2354)
Sell
CA Score
(Annual)
Level (-0.6178)
Sell
Beneish M-Score
(Annual)
Level (-1.0671)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.588)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.
Stock Forecast FAQ
In the current month, ARDX has received 10 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ARDX average analyst price target in the past 3 months is $11.70.
-
Where Will Ardelyx, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ardelyx, Inc. share price will rise to $11.70 per share over the next 12 months.
-
What Do Analysts Say About Ardelyx, Inc.?
Analysts are divided on their view about Ardelyx, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ardelyx, Inc. is a Sell and believe this share price will drop from its current level to $8.00.
-
What Is Ardelyx, Inc.'s Price Target?
The price target for Ardelyx, Inc. over the next 1-year time period is forecast to be $11.70 according to 11 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ARDX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ardelyx, Inc. is a Buy. 10 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ARDX?
You can purchase shares of Ardelyx, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ardelyx, Inc. shares.
-
What Is The Ardelyx, Inc. Share Price Today?
Ardelyx, Inc. was last trading at $6.15 per share. This represents the most recent stock quote for Ardelyx, Inc.. Yesterday, Ardelyx, Inc. closed at $5.83 per share.
-
How To Buy Ardelyx, Inc. Stock Online?
In order to purchase Ardelyx, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ARDX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARDX
Sector
P/E ratio
--
23.88x
PEG ratio
-0.11x
-0.01x
P/B ratio
9.18x
1.82x
Price / LTM sales
3.53x
1.59x
Growth Metrics
ARDX
Sector
Revenue growth
12.3%
4.73%
Earnings growth
-17.65%
11.11%
Revenue (5-year growth)
129.14%
6.46%
Earnings forecast
$0.01
-$0.18
Profitability
ARDX
Sector
Profitability FY 2024
$281M
$3.6M
Return on invested capital
-17.69%
-31.77%
Return on assets
-13.05%
-28.18%
Return on equity
-36.67%
-37.47%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Jan
29
Balance Sheet
ARDX
Sector
Total cash
$242.7M
$26.3M
Short term investments
$185.2M
$26M
Total assets
$435.8M
$76.9M
Long term debt
$206.2M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
45
CTEV alert for Jan 2
Claritev Corp. [CTEV] is down 20.7% over the past day.
Sell
47
ASTS alert for Jan 2
AST Spacemobile, Inc. [ASTS] is up 14.94% over the past day.
Sell
45
BIDU alert for Jan 2
Baidu, Inc. [BIDU] is up 15.01% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
